Eli Lilly: Cementing Its GLP-1 Empire With Orforglipron’s Promising Phase 3 Results

This article was written by Follow With a background as an RN and an MBA, I…

BlackRock Q1: Achieved Strong Results In A Tough Environment (NYSE:BLK)

This article was written by Follow David A. Johnson is founder and principal of Endurance Capital…

Jamf Holding Revenue Growth Drags On Results And Valuation (Downgrade) (NASDAQ:JAMF)

This article was written by Follow Donovan Jones is a research specialist with 15 years of…

Xero: All Eyes On Results Preview And U.S. Market Prospects (OTCMKTS:XROLF)

This article was written by Follow The Value Pendulum is an Asian equity market specialist with…